Warning! GuruFocus detected
1 Severe warning sign
with CBLL.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
CeriBell Inc
NAICS : 325413
SIC : 3845
ISIN : US15678C1027
Description
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.85 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -1.03 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 12.68 | |||||
| Beneish M-Score | -2.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate Estimate | 34.03 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 32.28 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.18 | |||||
| 9-Day RSI | 34.92 | |||||
| 14-Day RSI | 38.45 | |||||
| 3-1 Month Momentum % | -5.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.73 | |||||
| Quick Ratio | 16.19 | |||||
| Cash Ratio | 14.96 | |||||
| Days Inventory | 518.82 | |||||
| Days Sales Outstanding | 97.1 | |||||
| Days Payable | 117.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.08 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 87.46 | |||||
| Operating Margin % | -63.87 | |||||
| Net Margin % | -64.35 | |||||
| FCF Margin % | -101.83 | |||||
| ROA % | -23.92 | |||||
| ROIC % | -96.61 | |||||
| ROC (Joel Greenblatt) % | -162.5 | |||||
| ROCE % | -26.91 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 20.61 | |||||
| PB Ratio | 3.95 | |||||
| Price-to-Tangible-Book | 3.95 | |||||
| EV-to-EBIT | -25.55 | |||||
| EV-to-EBITDA | -26.28 | |||||
| EV-to-Revenue | 15.71 | |||||
| EV-to-Forward-Revenue | 6.64 | |||||
| EV-to-FCF | -15.24 | |||||
| Price-to-Net-Current-Asset-Value | 4.12 | |||||
| Price-to-Net-Cash | 4.71 | |||||
| Earnings Yield (Greenblatt) % | -3.91 | |||||
| FCF Yield % | -4.82 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers